Company Announcements

Director/PDMR Shareholding

Source: RNS
RNS Number : 3002W
Ovoca Bio PLC
15 July 2024
 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Timothy McCutcheon

 

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director, PDMR

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

0.85 pence per share

19,506,203

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

e)

Date of the transaction

 

12 July 2024

 

f)

Place of the transaction

 

Outside of a trading venue

 

g)

Additional Information

 

Following this transaction, Mr McCutcheon has an interest in 19,506,203 Ordinary Shares in Ovoca Bio plc, or 23.92% of the Issued Share Capital of the Company (excl. Treasury Shares)

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Kirill Golovanov

 

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer, PDMR

 

b)

Initial Notification Amendment

 

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Disposal of Ordinary Shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

0.85 pence per share

19,506,203

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

12 July 2024

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

g)

Additional Information

 

Following this transaction, Mr. Golovanov no longer holds any Ordinary Shares in Ovoca Bio plc

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKXAFALLEFA